Purple Biotech Ltd.
PPBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -0.1% | – | – |
| R&D Expenses | $8 | $17 | $16 | $12 |
| G&A Expenses | $3 | $5 | $6 | $6 |
| SG&A Expenses | $3 | $5 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | -$22 | $23 | $18 |
| Operating Income | -$11 | -$22 | -$23 | -$18 |
| % Margin | – | -11,374.1% | – | – |
| Other Income/Exp. Net | $4 | $2 | $1 | $0 |
| Pre-Tax Income | -$7 | -$20 | -$22 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7 | -$0 | -$22 | -$18 |
| % Margin | – | -10.2% | – | – |
| EPS | -4.42 | -0.16 | -0.23 | -0.21 |
| % Growth | -2,662.5% | 30.4% | -9.5% | – |
| EPS Diluted | -4.42 | -0.16 | -0.23 | -0.21 |
| Weighted Avg Shares Out | 3 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 3 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $0 | $2 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$7 | -$20 | -$21 | -$18 |
| % Margin | – | -10,150.5% | – | – |